Author:
Xiao Yuyao,Huang Peng,Zhang Yunfei,Lu Xin,Zhou Changwu,Wu Fei,Wang Yi,Zeng Mengsu,Yang Chun
Funder
National Natural Science Foundation of China
Shanghai Municipal Health Commission
Science and Technology Commission of Shanghai Municipality
Publisher
Springer Science and Business Media LLC
Subject
Urology,Gastroenterology,Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Reference27 articles.
1. World Health Organization (2019) WHO classification of tumours: digestive system tumours. World Health Organization, Geneva. Available via https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours/Digestive-System-Tumours-2019. Accessed 11 July 2019
2. Beaufrère A, Calderaro J, Paradis V. Combined hepatocellular-cholangiocarcinoma: An update. J Hepatol. 2021;74(5):1212-1224.
3. Zhou C, Lu X, Wang Y, Qian X, Yang C, Zeng M. Histopathological components correlated with MRI features and prognosis in combined hepatocellular carcinoma-cholangiocarcinoma. Eur Radiol. 2022;32(10):6702-6711.
4. Xiao Y, Zheng X, Zhou C, et al. Combined hepatocellular carcinoma-cholangiocarcinoma with a predominant HCC component: better survival and MRI-based prediction. Eur Radiol. 2023;33(2):1412-1421.
5. Lee WS, Lee KW, Heo JS, et al. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today. 2006;36(10):892-897.